{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:54:32Z","timestamp":1760576072641,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.numecd.2020.12.004","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T18:09:02Z","timestamp":1607623742000},"page":"1276-1285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapy"],"prefix":"10.1016","volume":"31","author":[{"given":"Matteo","family":"Nardin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Verdoia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Gioscia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Negro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.numecd.2020.12.004_bib1","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1160\/TH04-11-0726","article-title":"Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction","volume":"93","author":"De Luca","year":"2005","journal-title":"Thromb Haemostasis"},{"issue":"5","key":"10.1016\/j.numecd.2020.12.004_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pcad.2007.11.004","article-title":"Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status","volume":"50","author":"De Luca","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.numecd.2020.12.004_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.numecd.2020.12.004_bib4","first-page":"287","article-title":"Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial","volume":"19","author":"Brener","year":"2007","journal-title":"J Invasive Cardiol"},{"issue":"22","key":"10.1016\/j.numecd.2020.12.004_bib5","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.numecd.2020.12.004_bib6","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/01.CIR.103.21.2572","article-title":"Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study","volume":"103","author":"Steinhubl","year":"2001","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.numecd.2020.12.004_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.000703","article-title":"High on-aspirin platelet reactivity and clinical outcome in patients with stable coronary artery disease: results from ASCET (aspirin nonresponsiveness and clopidogrel endpoint trial)","volume":"1","author":"Pettersen","year":"2012","journal-title":"J Am Heart Assoc"},{"issue":"19","key":"10.1016\/j.numecd.2020.12.004_bib8","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1161\/CIRCULATIONAHA.105.573923","article-title":"Homocysteine and its effects on in-stent restenosis","volume":"112","author":"De Luca","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.thromres.2014.05.025","article-title":"Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study","volume":"134","author":"Schaffer","year":"2014","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.numecd.2020.12.004_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.numecd.2013.10.027","article-title":"MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting","volume":"24","author":"Verdoia","year":"2014","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2459\/JCM.0b013e32836574f0","article-title":"Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting","volume":"16","author":"Verdoia","year":"2015","journal-title":"J Cardiovasc Med (Hagerstown)."},{"issue":"15","key":"10.1016\/j.numecd.2020.12.004_bib12","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMe068060","article-title":"Homocysteine trials-clear outcomes for complex reasons","volume":"354","author":"Loscalzo","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.numecd.2020.12.004_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/09537104.2016.1204438","article-title":"Inhibition of glutamate receptors reduces the homocysteine-induced whole blood platelet aggregation but does not affect superoxide anion generation or platelet membrane fluidization","volume":"28","author":"Karolczak","year":"2017","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.numecd.2020.12.004_bib14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/09537104.2010.512646","article-title":"Integrin \u03b1(IIb)\u03b2\u2083 exists in an activated state in subjects with elevated plasma homocysteine levels","volume":"22","author":"McGarrigle","year":"2011","journal-title":"Platelets"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2362.2002.00971.x","article-title":"Effect of homocysteine on arachidonic acid release in human platelets","volume":"32","author":"Signorello","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.niox.2008.11.005","article-title":"Homocysteine decreases platelet NO level via protein kinase C activation","volume":"20","author":"Signorello","year":"2009","journal-title":"Nitric oxide Biol Chem"},{"key":"10.1016\/j.numecd.2020.12.004_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.phrs.2013.04.010","article-title":"Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study","volume":"74","author":"Karolczak","year":"2013","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00392-006-0363-1","article-title":"Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex\u00a0vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril","volume":"95","author":"Skowasch","year":"2006","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"10.1016\/j.numecd.2020.12.004_bib19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.RES.0000014434.48463.35","article-title":"Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179","volume":"90","author":"Kr\u00e4mer","year":"2002","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.numecd.2020.12.004_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2012.01.066","article-title":"Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients","volume":"60","author":"Willoughby","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"Pt A","key":"10.1016\/j.numecd.2020.12.004_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.05.008","article-title":"AT1 receptor signaling pathways in the cardiovascular system","volume":"125","author":"Kawai","year":"2017","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib22","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00005344-200310000-00016","article-title":"Captopril restores endothelium-dependent relaxation of rat aortic rings after exposure to homocysteine","volume":"42","author":"Fu","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3317\/jraas.2006.039","article-title":"The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats","volume":"7","author":"Kassab","year":"2006","journal-title":"J Renin-Angiotensin-Aldosterone Syst JRAAS"},{"issue":"1","key":"10.1016\/j.numecd.2020.12.004_bib24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/ATVBAHA.116.308515","article-title":"Elevated homocysteine concentrations decrease the antihypertensive effect of angiotensin-converting enzyme inhibitors in hypertensive patients","volume":"37","author":"Qin","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.numecd.2020.12.004_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41467-017-02401-7","article-title":"Homocysteine directly interacts and activates the angiotensin II type I receptor to aggravate vascular injury","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.numecd.2020.12.004_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/eci.12281","article-title":"Vitamin D deficiency is independently associated with the extent of coronary artery disease","volume":"44","author":"Verdoia","year":"2014","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MBC.0b013e32835d546e","article-title":"PlA(1)\/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty","volume":"24","author":"Verdoia","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.numecd.2020.12.004_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1751-553X.2012.01428.x","article-title":"Role of the laboratory in monitoring patients receiving dual antiplatelet therapy","volume":"34","author":"Vidali","year":"2012","journal-title":"Int J Lab Hematol"},{"issue":"7","key":"10.1016\/j.numecd.2020.12.004_bib29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.numecd.2020.12.004_bib30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/09537104.2011.625098","article-title":"Roles of Mac-1 and glycoprotein IIb\/IIIa integrins in leukocyte-platelet aggregate formation: stabilization by Mac-1 and inhibition by GpIIb\/IIIa blockers","volume":"23","author":"Patko","year":"2012","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.numecd.2020.12.004_bib31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijcard.2011.11.102","article-title":"A meta-analytic overview of thrombectomy during primary angioplasty","volume":"166","author":"De Luca","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2020.12.004_bib32","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.ijcard.2013.01.161","article-title":"Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI","volume":"168","author":"De Luca","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2010.08.063","article-title":"Meta-analysis of randomized trials of glycoprotein IIb\/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy","volume":"107","author":"De Luca","year":"2011","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2020.12.004_bib34","first-page":"1","article-title":"Regulation of platelet activation and coagulation and its role in vascular injury and arterial thrombosis","volume":"6","author":"Tomaiuolo","year":"2017","journal-title":"Interv Cardiol Clin"},{"issue":"1469","key":"10.1016\/j.numecd.2020.12.004_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1098\/rstb.2005.1775","article-title":"Adventures in vascular biology: a tale of two mediators","volume":"361","author":"Moncada","year":"2006","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.numecd.2020.12.004_bib36","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","author":"Knuuti","year":"2019","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.numecd.2020.12.004_bib37","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00392-008-0668-3","article-title":"RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection","volume":"97","author":"Werner","year":"2008","journal-title":"Clin Res Cardiol"},{"issue":"15","key":"10.1016\/j.numecd.2020.12.004_bib38","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1161\/01.CIR.99.15.2027","article-title":"Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system","volume":"99","author":"Warnholtz","year":"1999","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.CIR.0000021122.63813.32","article-title":"Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice","volume":"106","author":"Candido","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1067\/mhj.2003.22","article-title":"Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry","volume":"145","author":"Bauriedel","year":"2003","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/01.HYP.0000034745.98129.EC","article-title":"Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release","volume":"40","author":"Kalinowski","year":"2002","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"6","key":"10.1016\/j.numecd.2020.12.004_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/00005344-200006000-00012","article-title":"Comparative effects of angiotensin II AT-1-type receptor antagonists in\u00a0vitro on human platelet activation","volume":"35","author":"Mont\u00f3n","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib43","doi-asserted-by":"crossref","first-page":"E58","DOI":"10.1161\/01.RES.0000012569.55432.02","article-title":"Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide\/cGMP signaling","volume":"90","author":"Mollnau","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2020.12.004_bib44","doi-asserted-by":"crossref","first-page":"9040457","DOI":"10.1155\/2016\/9040457","article-title":"Ramipril and losartan exert a similar long-term effect upon markers of heart failure, endogenous fibrinolysis, and platelet aggregation in survivors of ST-elevation myocardial infarction: a single centre randomized trial","volume":"2016","author":"Marin\u0161ek","year":"2016","journal-title":"BioMed Res Int"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jacc.2004.03.065","article-title":"Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease","volume":"44","author":"Schieffer","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.numecd.2020.12.004_bib46","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","article-title":"Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"7374","key":"10.1016\/j.numecd.2020.12.004_bib47","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","article-title":"Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis","volume":"325","author":"Wald","year":"2002","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib48","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/clinchem\/31.4.624","article-title":"Radioenzymic determination of homocysteine in plasma and urine","volume":"31","author":"Refsum","year":"1985","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"issue":"33","key":"10.1016\/j.numecd.2020.12.004_bib50","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.numecd.2020.12.004_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.jhh.1002325","article-title":"Effect of ACE inhibitors and beta-blockers on homocysteine levels in essential hypertension","volume":"22","author":"Poduri","year":"2008","journal-title":"J Hum Hypertens"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/1076029614565881","article-title":"Elevation in total homocysteine levels in Chinese patients with essential hypertension treated with antihypertensive benazepril","volume":"22","author":"Jiang","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib53","doi-asserted-by":"crossref","first-page":"H92","DOI":"10.1152\/ajpheart.00577.2014","article-title":"Role of homocysteinylation of ACE in endothelial dysfunction of arteries","volume":"308","author":"Huang","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"12","key":"10.1016\/j.numecd.2020.12.004_bib54","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1515\/CCLM.2007.354","article-title":"Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling","volume":"45","author":"Sen","year":"2007","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.numecd.2020.12.004_bib55","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1046\/j.1523-1755.1999.0550031028.x","article-title":"Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus","volume":"55","author":"Wollesen","year":"1999","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.numecd.2020.12.004_bib56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.numecd.2019.09.018","article-title":"Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor","volume":"30","author":"Verdoia","year":"2020","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.numecd.2020.12.004_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/FJC.0000000000000240","article-title":"Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid","volume":"66","author":"Verdoia","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"issue":"26","key":"10.1016\/j.numecd.2020.12.004_bib58","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa032845","article-title":"Folate therapy and in-stent restenosis after coronary stenting","volume":"350","author":"Lange","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.numecd.2020.12.004_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000441478","article-title":"Impact of diabetes on homocysteine levels and its relationship with coronary artery disease: a single-centre cohort study","volume":"68","author":"Schaffer","year":"2016","journal-title":"Ann Nutr Metab"},{"issue":"5","key":"10.1016\/j.numecd.2020.12.004_bib60","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/bab.1799","article-title":"Combinational effect of angiotensin receptor blocker and folic acid therapy on uric acid and creatinine level in hyperhomocysteinemia-associated hypertension","volume":"66","author":"Singh","year":"2019","journal-title":"Biotechnol Appl Biochem"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320305135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475320305135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:18:22Z","timestamp":1760545102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475320305135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0939475320305135"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2020.12.004","relation":{},"ISSN":["0939-4753"],"issn-type":[{"type":"print","value":"0939-4753"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of renin angiotensin system inhibitors on homocysteine levels and platelets reactivity in patients on dual antiplatelet therapy","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2020.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}